All of us in the Biomaterials Science Editorial team would like to wish you all a merry Christmas and a happy new year! The Editorial office will be closed from 21 December 2012 and will reopen on 2 January 2013.
We’re really looking forward to 2013, which will see more high quality articles from top international biomaterials scientists and much more.
Don’t miss out on all the journal news – follow us on twitter @BioMaterSci and like us on Facebook!
Professor Sarah Heilshorn, Editorial Board member
Sarah Heilshorn completed her undergraduate studies in chemical engineering at Georgia Tech. She then earned her MS and PhD in chemical engineering at the California Institute of Technology (Caltech) under the supervision of David A. Tirrell. While a graduate student, she was also a visiting scholar in the Department of Polymer Science at the Kyoto Institute of Technology through a National Science Foundation East Asia Fellowship. She was awarded the Caltech Everhart Lectureship for her PhD thesis work in 2004. Following this, Prof. Heilshorn was a postdoctoral scholar with Mu-ming Poo at the University of California, Berkeley in the Department of Molecular and Cell Biology. In 2006 she joined Stanford University as an Assistant Professor in the Department of Materials Science & Engineering. She also holds courtesy faculty appointments in the Departments of Bioengineering and Chemical Engineering. Her research laboratory studies the dynamics of biological and bio-inspired systems at multiple length scales, including the molecular through to the multi-cellular level. Current topics of investigation include the design of injectable materials for stem cell and drug delivery, protein-engineered materials for regenerative medicine scaffolds, and peptide-based self-assembly materials for templated nanoparticle synthesis. In 2009, she was selected for the National Science Foundation CAREER Award and the National Institutes of Health New Innovator Award for young faculty.
Biomaterials Science is now accepting submissions. All articles will be free to access until the end of 2014. Please contact the editorial office if you have any questions about the journal.
Follow the latest journal news on Twitter @BioMaterSci or go to our Facebook page.
To keep up-to-date with all the latest research, sign-up to our RSS feed or Table of contents alert.
DNA nanotechnology allows the construction of self-assembled scaffolds for use in the arrangement of functional molecules and nanomaterials. These can be used to create complex molecular devices. DNA origami is a new programmed DNA assembly system that enables the design of 2D nanostructures which can be functionalised with molecules and nanoparticles.
This Review by Endo, Yang and Sugiyama covers the rapidly moving field of DNA materials science. The review describes the state of current DNA origami research and describes its applications in biomaterials such as the selective functionalisation and single molecule imaging of biomolecules; cell-targeting and as a basis for molecular machines.
DNA origami technology for biomaterials applications
Biomater. Sci., 2012, Advance Article. DOI: 10.1039/c2bm00154c
Follow the latest journal news on Twitter @BioMaterSci or go to our Facebook page.
To keep up-to-date with all the latest research, sign-up to our RSS feed or Table of contents alert.
Prof. Patrick S. Stayton, Editorial Board member
Patrick Stayton currently serves as the Washington Research Foundation Professor in the Department of Bioengineering at the University of Washington. He is the founding Director of the Institute for Molecular Engineering and Sciences, and the Center for Intracellular Delivery of Biologics. He received his B.S. in Biology (summa cum laude) from Illinois State University in 1984, his Ph.D. in Biochemistry from the University of Illinois in 1989, and was a Postdoctoral Research Associate at the Beckman Institute for Advanced Science and Technology, also at the University of Illinois.
Dr. Stayton’s eclectic research group works at the interface of fundamental molecular science and applied molecular bioengineering. His laboratory has fundamental projects aimed at elucidating the basic principles underlying biomolecular recognition, and connected projects applying these principles to medical applications in the drug delivery, medical diagnostics, and regenerative medicine fields. He has published over 200 scientific papers. Dr. Stayton has a strong interest in translating the group’s research, has been awarded several patents, and is a co-founder of the startup companies PhaseRx Inc. based on his group’s biologic drug delivery work, and Nexgenia based on their diagnostic work.
Dr. Stayton has been elected as a Fellow of the American Institute for Medical and Biological Engineering, and has been the recipient of the Clemson Award from the Society For Biomaterials and the CRS-Cygnus Recognition Award from the Controlled Release Society. He served as Co-Chair of the Gordon Conference on Drug Carriers in Medicine and Biology in 2010. He has also been awarded the 2009 Faculty Research Innovation Award, UW College of Engineering, and the Distinguished Teacher and Mentor Award from the Department of Bioengineering.
Biomaterials Science is now accepting submissions. All articles will be free to access until the end of 2014. Please contact the editorial office if you have any questions about the journal.
Follow the latest journal news on Twitter @BioMaterSci or go to our Facebook page.
To keep up-to-date with all the latest research, sign-up to our RSS feed or Table of contents alert.
